Ophelia Expands Access to Opioid Addiction Treatment Across New York State, Now In-Network with MVP Healthcare

Key Facts

"Our partnerships with forward-thinking insurers like MVP Healthcare are pivotal in providing people living with OUD throughout the state of New York with an effective treatment model that focuses on both cost and outcomes."
With support from care coordinators, patients are set up with an Ophelia clinician via telehealth appointment and, if eligible, can be prescribed Suboxone, a combination medication of Buprenorphine and Naloxone, a partial opioid that binds to the same receptors in the brain as traditional opioids and reduces cravings and withdrawal symptoms.
About Ophelia Ophelia is a digital provider of medication-assisted treatment (MAT) for opioid use disorder (OUD), committed to making evidence-based treatment universally accessible.
Its mission is to remove barriers for the 80% of Americans with OUD who are unable to access care and the 50,000+ MAT clinicians who are unable to treat patients due to a lack of infrastructure, training, and support.